Dr Desmond Hau, CEO of Pangenia Inc, recently accepted an interview with Pharma Boardroom, a global professional information platform in the field of Healthcare & the Life Sciences. In the latest release of PharmaBoardroom's InFocus Precision Medicine in 2020, he talked about Pangenia‘s experience in the past three years and also mentioned the future development. Desmond hopes to gradually expand Hong Kong's local brands to Southeast Asia and other places, so that Hong Kong can occupy a place in the world's biotechnology industry.
Despite its small population, Hong Kong has long had strategic interests in the healthcare and life sciences industries, whether as a test platform for innovative products and service delivery models, as an effective regulatory approval system or as an incubator for start-ups. Companies that penetrate the Chinese mainland and international markets.
Pharma Boardroom has penetrated into major national markets and conducted hundreds of exclusive interviews with industry promoters and shockers. By capturing their opinions, Pharma Boardroom created an experience-based study to understand the challenges and opportunities in these markets.
Pharma Boardroom is the premier website for C-level executives, consultants, regulators and vendors working in Healthcare & the Life Sciences globally. Through interviews with senior professionals in the local and global markets, the website allows the industry to benefit from field experience and apply it to various fields.
Note: C-level executive: Common C-level executives include Chief Executive Officer (CEO), Chief Operations Officer (COO) and Chief Financial Officer (CFO).
For details, please visit: https://pharmaboardroom.com/interviews/desmond-hau-ceo-pangenia-group/